What is the approximate market price range for a box of Upadacitinib?

Upadacitinib (Upadacitinib), as a JAK inhibitor for the treatment of various immune diseases, has been marketed in many countries and regions around the world, and has entered the medical insurance reimbursement list in some places. The price of upadatinib is affected by many factors, including manufacturers, market demand, exchange rate fluctuations, etc. In China, the original drug of upadatinib has been approved and marketed, and is usually used to treat diseases such as rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis.

In China, the common specification of upadatinib is15mg*28 tablets, and the price per box is about 2,000 yuan. This price is relatively affordable, especially for patients who need to take it for a long time. In addition, upadatinib has been included in the scope of medical insurance reimbursement in some areas, which means that eligible patients can reduce treatment costs through medical insurance reimbursement. This undoubtedly provides financial support to patients who need to use upadatinib and helps them obtain better treatment.

In the international market, the price of upadatinib is usually higher, especially in developed countries such as Europe and the United States. For example, in Europe, the price of upadatinib's original drug may reach more than 20,000 yuan per box. The specific selling price varies according to the country and region's medical system, drug import taxes and other factors.

In addition, the generic drug market in countries such as Laos offers more economical options. Although these generic versions of the drugs have significant price advantages, they are essentially identical in composition and therapeutic effects to the original drugs. For example, each box of generic upadatinib produced by Lucius Pharmaceuticals in Laos sells for about 500 yuan. The price of generic drugs is much lower than that of original drugs, making some patients with limited financial conditions able to afford treatment. The quality and safety of generic drugs are usually strictly regulated, but patients still need to ensure that the source of the drug is formal when purchasing to avoid the risk of counterfeit and substandard drugs.

Reference materials:https://www.rinvoq.com/